chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Diarrhoea; Fever; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified gender and age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on 12Apr2021 as dose 1, single for covid-19 immunization. Patient relevant medical history includes Covid from 04Apr2020 to unspecified date. The patient concomitant medications were not reported. The patient had COVID last 04Apr2020, so the patient took the, so the patient did antibody test on this Jan2021 and still had antibody. So, on 12Apr2021 the patient went to get first dose (captured as COVID 19 Vaccine) of the Pfizer, so exactly 2 weeks after the patient had the same reaction that the patient had, everything back like diarrhea, fever, chills, headache all those side effects. So, the patient trying to find out if the patient should get second shot because there was information out there that was saying that people who already had COVID after the first dose would be suspicion, suspicion immune cells to give protection. But first the patient wants to report it because it happened 2 weeks after first shot that did not sound normal. The patient had no more calls about, because it was different from people who had COVID and people who did not had COVID, so people who had COVID already had antibodies. It was natural that people who had COVID already had antibodies and when you inject the vaccine and had a reaction. The patient said they had enough antibodies what the patient wanted to know was that. The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema
Clinical narrative: The injection spot became red and rashes on right side torso; The injection spot became red and rashes on right side torso; This is a spontaneous report received from a contactable consumer (Patient reported for herself). A 56-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: 0165), via an unspecified route of administration, administered in Arm left on 28Apr2021 16:45 (at the age of 56 years old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient was not having any known allergies. The concomitant medication included multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient was not tested for COVID-19. The patient was not pregnant at time of vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: 8729), via an unspecified route of administration, administered in Arm left on 07Apr2021 05:30 PM as dose 1, single for COVID-19 immunisation and experienced mild fever and tiredness, nausea and shingles appeared on right arm. On 30Apr2021 after second dose the patient experienced the injection spot became red and rashes on right side torso. The outcome of the events was reported as unknown.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Neck pain, Pain in extremity
Clinical narrative: Arm pain; Headache; Back neck and joint pain; Back neck and joint pain; Back neck and joint pain; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 38-years-old female non pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0172) via an unspecified route of administration in right arm on 30Apr2021 at 13:15 (at the age of 38 years old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not a pregnant at the time of vaccination. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0151) via an unspecified route of administration in right arm on 09Apr2021 at 13:15 as dose 1, single for COVID-19 immunization and experienced arm pain after dose 1 from 6-30 hours afterward and missed period (was scheduled to get 4/23-4/25). Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination reported as birth control. Prior to vaccination patient was not diagnosed with COVID-19 and. Since the vaccination, patient has not been tested for COVID-19. The patient experienced arm pain, headache, Back neck and joint pain from 3-33 hours after 2nd dose on an unspecified date in 2021. The clinical outcome of all events was unknown.  Device Date: 02May2021  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Visual impairment
Clinical narrative: She is having trouble seeing out of the left eye; face was fluffy; This is a spontaneous report from a contactable consumer (patient).   A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0154, expiration date: unknown) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was having trouble seeing out of the left eye and her face was fluffy. The patient got Pfizer vaccine, the first dose and was having an adverse reaction. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Pruritus
Clinical narrative: After receiving the second dose I still felt itchy, but this time the itching was a little stronger; After receiving the second dose I still felt itchy, but this time the itching was a little stronger; This is a spontaneous report from a contactable consumer (patient). A 56-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) dose 2 via an unspecified route of administration on 28Apr2021 as DOSE 2, SINGLE for covid-19 immunisation (at the age 56 years). Medical history included, limb operation from 22Apr2021 to an unknown date and hypersensitivity from 2021 to an unknown date. The patient's concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced i still felt itchy, but this time the itching was a little stronger an unknown date in 2021. He received both doses of the Pfizer Covid 19 vaccine, on April 28th he received the second dose. After the first dose, almost at 3 weeks he began to feel mild itching between his fingers, between the joints. behind the ears, behind the head, on the feet and knees. Not everywhere at the same time. Before the second dose, on April 22nd I had surgery on one of the fingers in his left hand, at first he thought the anesthesia had caused him allergy. After receiving the second dose he still felt itchy, but this time the itching was a little stronger. Therapeutic measures were taken as a result of event included allergy medication. The patient went to the doctor, to the ER and they gave him allergy medication but it didn't work for him. He still had the itching and if he got hit anywhere on the body, instead of feeling pain, he felt itching. The clinical outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure decreased, Blood pressure measurement, Blood test, Disturbance in attention
Clinical narrative: Lost use of legs after the second dose of the Covid Vaccine; Very weak after second dose of the Covid Vaccine; Blood Pressure has dropped drastically (90's systolic and 40's diastolic); Kidney problem requiring antibiotics; Trouble comprehending, loss of focus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8734), dose 2 via an unspecified route of administration, administered in the left arm on 09Apr2021 (at the age of 73 years old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. No family medical history relevant to AE. No illness at time of vaccination. The patient concomitant medication was not reported. No other vaccines were given within 4 weeks. The patient previously took Bactrim and experienced urticaria. Patient also received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6208), dose 1 via an unspecified route of administration, administered in the left arm on 19Mar2021 as dose 1, single for COVID-19 immunization. No additional vaccines were administered on same date of the Pfizer suspect. On unspecified date of Apr2021, the patient experienced lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine, blood pressure has dropped drastically, kidney problem requiring antibiotics and on an unspecified date of 2021 the patient had trouble comprehending, loss of focus. All events resulted to physician office visit but not emergency room. The patient underwent lab tests and procedures which included blood pressure resulted 40/90 mmHg on unspecified date of Apr2021 (dropped drastically), blood test with lab work for her kidneys and blood work done on unspecified date of Apr2021. Therapeutic measures were taken as a result of kidney problem requiring antibiotics. Reporter states she thinks it should be noted that the vaccine can cause heart problems. States the vaccine can do more than what they are saying it can do, states it can kill a person and she had no symptoms before the vaccines. The clinical outcome of the events blood pressure has dropped drastically, kidney problem requiring antibiotics was reported as unknown, lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine was reported as not recovered, trouble comprehending, loss of focus was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Renal disorder
Clinical narrative: Lost use of legs after the second dose of the Covid Vaccine; Very weak after second dose of the Covid Vaccine; Blood Pressure has dropped drastically (90's systolic and 40's diastolic); Kidney problem requiring antibiotics; Trouble comprehending, loss of focus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8734), dose 2 via an unspecified route of administration, administered in the left arm on 09Apr2021 (at the age of 73 years old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. No family medical history relevant to AE. No illness at time of vaccination. The patient concomitant medication was not reported. No other vaccines were given within 4 weeks. The patient previously took Bactrim and experienced urticaria. Patient also received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6208), dose 1 via an unspecified route of administration, administered in the left arm on 19Mar2021 as dose 1, single for COVID-19 immunization. No additional vaccines were administered on same date of the Pfizer suspect. On unspecified date of Apr2021, the patient experienced lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine, blood pressure has dropped drastically, kidney problem requiring antibiotics and on an unspecified date of 2021 the patient had trouble comprehending, loss of focus. All events resulted to physician office visit but not emergency room. The patient underwent lab tests and procedures which included blood pressure resulted 40/90 mmHg on unspecified date of Apr2021 (dropped drastically), blood test with lab work for her kidneys and blood work done on unspecified date of Apr2021. Therapeutic measures were taken as a result of kidney problem requiring antibiotics. Reporter states she thinks it should be noted that the vaccine can cause heart problems. States the vaccine can do more than what they are saying it can do, states it can kill a person and she had no symptoms before the vaccines. The clinical outcome of the events blood pressure has dropped drastically, kidney problem requiring antibiotics was reported as unknown, lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine was reported as not recovered, trouble comprehending, loss of focus was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number and Expiry date: not provided) (age at the time of vaccination was 71 years), via unspecified route on an unspecified date as dose number unknown, single for COVID-19 immunization. On an unknown date, the patient experienced after three weeks of vaccination. The patient still have hives and they were getting worse. No further details provided. The outcome of the event was not resolved.   No further information was provided. Batch/lot number not obtained.
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Inflammatory marker test
Clinical narrative: inflammation markers popped; This is a spontaneous report from a contactable consumer (patient's mother).  An adult male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient's mother reported that his inflammation makers popped right around the time he got COVID-19 vaccine. They were back to normal later on an unspecified date however his doctor wanted them to be even lower. The patient underwent lab tests and procedures on an unspecified date which showed inflammation markers popped. The outcome of the event was unknown at the time of report.   No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: fever; headache; This is a spontaneous report from a sponsored program.   A contactable physician reported that a female patient of an unspecified age received BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. The patient experienced fever and headache after the second dose on an unknown date and would like to know if it was okay to give tylenol for the patient. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: after received second dose, bruising; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. Patient stated she had received both doses of vaccine and after receiving the second dose experienced bruising on an unspecified date. Patient was calling on behalf of her sister who was unvaccinated and referenced "she heard being in contact" with those could impede menstrual cycle. Patient enquired about defining exposures during pregnancy, including through inhalation or skin contact and response included that there were no known risks of skin contact or inhalation exposure to the vaccine following routine administration of the vaccine during pregnancy or from inhaling the air from a vaccinated individual. Patient stated that she heard of children getting nosebleeds. Patient was asking cardiologist and indicated she bumped into something. The outcome of event was unknown.  No follow up attempts are needed; No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Groin pain, Headache, Pain
Clinical narrative: sever leg pain; She has pain in the legs, hips and groin area; She has pain in the legs, hips and groin area; severe headache; intense chills; needle pain started after the vaccine which comes and go/ in the whole body, arm legs, chest, back, ankle.; second dose was  more colorful; second dose was  more colorful; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 25Mar2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included vision changes about 3 years ago. Concomitant medications were reported as none. Historical vaccine included first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 04Mar2021 for COVID-19 immunization. On 25Mar2021, the patient reported that second dose was more colorful and experienced random pins and needle pain started after the vaccine which comes and go, it is in the whole body, arm legs, chest, back, ankle. On an unspecified date, the patient experienced sever leg pain which was unbearable for 2-3 days, pain in the legs, hips and groin area, next day woke up with severe headache and intense chills. The patient reported that she was seeing a neurologist for random pins and needle pain. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Poor quality product administered, Product colour issue
Clinical narrative: sever leg pain; She has pain in the legs, hips and groin area; She has pain in the legs, hips and groin area; severe headache; intense chills; needle pain started after the vaccine which comes and go/ in the whole body, arm legs, chest, back, ankle.; second dose was  more colorful; second dose was  more colorful; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 25Mar2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included vision changes about 3 years ago. Concomitant medications were reported as none. Historical vaccine included first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 04Mar2021 for COVID-19 immunization. On 25Mar2021, the patient reported that second dose was more colorful and experienced random pins and needle pain started after the vaccine which comes and go, it is in the whole body, arm legs, chest, back, ankle. On an unspecified date, the patient experienced sever leg pain which was unbearable for 2-3 days, pain in the legs, hips and groin area, next day woke up with severe headache and intense chills. The patient reported that she was seeing a neurologist for random pins and needle pain. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: sever leg pain; She has pain in the legs, hips and groin area; She has pain in the legs, hips and groin area; severe headache; intense chills; needle pain started after the vaccine which comes and go/ in the whole body, arm legs, chest, back, ankle.; second dose was  more colorful; second dose was  more colorful; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 25Mar2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included vision changes about 3 years ago. Concomitant medications were reported as none. Historical vaccine included first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was reported), via an unspecified route of administration on 04Mar2021 for COVID-19 immunization. On 25Mar2021, the patient reported that second dose was more colorful and experienced random pins and needle pain started after the vaccine which comes and go, it is in the whole body, arm legs, chest, back, ankle. On an unspecified date, the patient experienced sever leg pain which was unbearable for 2-3 days, pain in the legs, hips and groin area, next day woke up with severe headache and intense chills. The patient reported that she was seeing a neurologist for random pins and needle pain. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Groin pain, Headache, Pain
Clinical narrative: sudden intense pain in the left foot , both hips; sudden intense pain in the left foot , sore arm; This is a spontaneous report from a contactable consumer (patient).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient after the second dose, she had sever leg pain which was unbearable for 2-3 days. She has pain in the legs, hips and groin area, next day she woke up with severe headache, intense chills, she is seeing a neurologist for random pins and needle pain started after the vaccine which comes and go. Its in the whole body, arm legs, chest, back, ankle. It stated immediately after the vaccine. Caller wanted to know other reports about it. She stated she does not take any other medication, in the past about 3 years ago she did have some  vision changes, its unrelated. The outcome events were unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Poor quality product administered, Product colour issue
Clinical narrative: sudden intense pain in the left foot , both hips; sudden intense pain in the left foot , sore arm; This is a spontaneous report from a contactable consumer (patient).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient after the second dose, she had sever leg pain which was unbearable for 2-3 days. She has pain in the legs, hips and groin area, next day she woke up with severe headache, intense chills, she is seeing a neurologist for random pins and needle pain started after the vaccine which comes and go. Its in the whole body, arm legs, chest, back, ankle. It stated immediately after the vaccine. Caller wanted to know other reports about it. She stated she does not take any other medication, in the past about 3 years ago she did have some  vision changes, its unrelated. The outcome events were unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: sudden intense pain in the left foot , both hips; sudden intense pain in the left foot , sore arm; This is a spontaneous report from a contactable consumer (patient).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient after the second dose, she had sever leg pain which was unbearable for 2-3 days. She has pain in the legs, hips and groin area, next day she woke up with severe headache, intense chills, she is seeing a neurologist for random pins and needle pain started after the vaccine which comes and go. Its in the whole body, arm legs, chest, back, ankle. It stated immediately after the vaccine. Caller wanted to know other reports about it. She stated she does not take any other medication, in the past about 3 years ago she did have some  vision changes, its unrelated. The outcome events were unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in jaw, Swelling face
Clinical narrative: pain in his jaw; Joint pain; Face actually look a little swollen one side; This is a spontaneous report from contactable consumer. The reporter reported for her husband. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Unknown, Expiry date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were none. On an unspecified date, the patient experienced severe pain in his jaw, joint pain and face actually looks a little swollen one side. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: my arm was sore; I had a rash on where they gave the shot; This is a spontaneous report from a contactable Other Health Professional. An adult male patient of an unspecified age (age mentioned as 60-64 years) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported), as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm sore and had a rash on where they gave the shot, and he reported that he did not feel anything bad. The outcome of the events was unknown at the time of this report. The reporter causality between the event and bnt162b2 reported as related  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: experienced a high fever (103.6 degrees Fahrenheit) for 6 hours; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as dose 2, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single dose for COVID-19 immunization. On an unspecified date, within 24 hours of receiving the second COVID vaccine dose, the patient experienced a high fever (103.6 degrees Fahrenheit) for 6 hours. Event took place after use of product. The patient underwent lab test and procedure include Body temperature with 103.6 degrees Fahrenheit for 6 hours. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Lung disorder
Clinical narrative: Coughing every morning; Has been having to take rescue inhaler more often than normal; This is a spontaneous report from a contactable consumer (patient). A 46-Year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution of injection, Lot Number: EW0162) via an unspecified route of administration on 22Apr2021 (at the age of 46 years old) as dose 2, single for COVID-19 immunization (Hospital). The patient medical history included acute anxiety disorder, depression, bipolar disorder, high cholesterol, high blood pressure, chronic head pain and cough in the morning started a year or 2 years ago but continues from an unknown date and ongoing. The patient concomitant medication included Emgality (GALCANEZUMAB) from an unspecified date for chronic head pain. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution of injection, Lot number: EW0150) via an unspecified route of administration on 01Apr2021 (at the age of 46 years old) as dose 1, single for COVID-19 immunization. The patient had not visited emergency room or physician office. Patient had not administered vaccine at military facility. On an unspecified date of 2021, the patient experienced has been having to take rescue inhaler more often than normal while an unspecified date the patient experienced coughing every morning. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity, Speech disorder, Swollen tongue
Clinical narrative: My tongue was swollen up; tongue was like deformed, half to my tongue was swelling and the other half wasn't; Allergic reaction; facing difficulty while speaking; This is a spontaneous report from a contactable consumer (Patient).   A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration on 03May2021 at single dose for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The historic vaccine included first dose of bnt162b2 (Batch/Lot Number: EN6205) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. After last shot of the Pfizer COVID-19, on 03May2021 (yesterday, from day of report), the patient came home, laid down and went to sleep at about 9:30 o'clock. Then the patient's tongue was swollen up and it took a long time for the swelling to go away. It was like big swollen, deformed, half of tongue was swollen, and the other half was not, so the patient got up and was wondering. The patient reported that probably it was an allergic reaction (Patient was unsure hence, not captured as event) from the shot that the patient had got yesterday, from the day of report. The patient just want to put it on record that tongue was swollen. When the patient got up this morning, (on the day of report, 04May2021) it was feeling small but it had gone down very slow. The patient was facing difficulty while speaking. Reporter seriousness for My tongue was swollen up; tongue was like deformed, half to my tongue was swelling and the other half wasnot: unspecified. The clinical outcome of events My tongue was swollen up; tongue was like deformed, half to my tongue was swelling and the other half wasnot: recovering and other events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: muscle ache; Chill; Fever; Arm pain that I can hardly lift my arm up; Joint pain; where they gave me the shot at my muscle was sore; This is a spontaneous report from a contactable consumer (patient herself). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8736, Expiration date: Unknown), via an unspecified route of administration in left arm on 03May2021 as dose 1, single (at the age of 61-years-old) for COVID-19 immunization. The patient's medical history included chronic obstructive pulmonary disease, gout, psoriasis, sinuses and arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications included triamcinolone taken for psoriasis; ibuprofen taken for pain in extremity; nifedipine taken for gastroesophageal reflux disease; famotidine taken one every day for an unspecified indication; salbutamol (ALBUTEROL HFA) taken for an unspecified indication; ascorbic acid (VITAMIN C MP) taken 2 daily for an unspecified indication and unspecified inhaler for her sinuses, start and stop date were not reported. The patient experienced muscle sore, muscle ache, chill, fever, arm pain that she could hardly lift her arm up and joint pain on an unspecified date. It was reported that she had side effects from the shot that she got yesterday for COVID-19. She went for to get her COVID-19 shot yesterday and she had side effects on the where they gave her the shot at her muscle was sore. She was having muscle ache, chill, fever and arm pain. It was reported that she felt like it's gone into her arm, in her armpit she was still freeze. It's kind of say in that progressing little bit. The patient did not receive any treatment in response to the events. The outcome of the events was unknown.   No follow up attempts are needed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle ache; Chill; Fever; Arm pain that I can hardly lift my arm up; Joint pain; where they gave me the shot at my muscle was sore; This is a spontaneous report from a contactable consumer (patient herself). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8736, Expiration date: Unknown), via an unspecified route of administration in left arm on 03May2021 as dose 1, single (at the age of 61-years-old) for COVID-19 immunization. The patient's medical history included chronic obstructive pulmonary disease, gout, psoriasis, sinuses and arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications included triamcinolone taken for psoriasis; ibuprofen taken for pain in extremity; nifedipine taken for gastroesophageal reflux disease; famotidine taken one every day for an unspecified indication; salbutamol (ALBUTEROL HFA) taken for an unspecified indication; ascorbic acid (VITAMIN C MP) taken 2 daily for an unspecified indication and unspecified inhaler for her sinuses, start and stop date were not reported. The patient experienced muscle sore, muscle ache, chill, fever, arm pain that she could hardly lift her arm up and joint pain on an unspecified date. It was reported that she had side effects from the shot that she got yesterday for COVID-19. She went for to get her COVID-19 shot yesterday and she had side effects on the where they gave her the shot at her muscle was sore. She was having muscle ache, chill, fever and arm pain. It was reported that she felt like it's gone into her arm, in her armpit she was still freeze. It's kind of say in that progressing little bit. The patient did not receive any treatment in response to the events. The outcome of the events was unknown.   No follow up attempts are needed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pain, Pain in extremity
Clinical narrative: muscle ache; Chill; Fever; Arm pain that I can hardly lift my arm up; Joint pain; where they gave me the shot at my muscle was sore; This is a spontaneous report from a contactable consumer (patient herself). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8736, Expiration date: Unknown), via an unspecified route of administration in left arm on 03May2021 as dose 1, single (at the age of 61-years-old) for COVID-19 immunization. The patient's medical history included chronic obstructive pulmonary disease, gout, psoriasis, sinuses and arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications included triamcinolone taken for psoriasis; ibuprofen taken for pain in extremity; nifedipine taken for gastroesophageal reflux disease; famotidine taken one every day for an unspecified indication; salbutamol (ALBUTEROL HFA) taken for an unspecified indication; ascorbic acid (VITAMIN C MP) taken 2 daily for an unspecified indication and unspecified inhaler for her sinuses, start and stop date were not reported. The patient experienced muscle sore, muscle ache, chill, fever, arm pain that she could hardly lift her arm up and joint pain on an unspecified date. It was reported that she had side effects from the shot that she got yesterday for COVID-19. She went for to get her COVID-19 shot yesterday and she had side effects on the where they gave her the shot at her muscle was sore. She was having muscle ache, chill, fever and arm pain. It was reported that she felt like it's gone into her arm, in her armpit she was still freeze. It's kind of say in that progressing little bit. The patient did not receive any treatment in response to the events. The outcome of the events was unknown.   No follow up attempts are needed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: muscle ache; Chill; Fever; Arm pain that I can hardly lift my arm up; Joint pain; where they gave me the shot at my muscle was sore; This is a spontaneous report from a contactable consumer (patient herself). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8736, Expiration date: Unknown), via an unspecified route of administration in left arm on 03May2021 as dose 1, single (at the age of 61-years-old) for COVID-19 immunization. The patient's medical history included chronic obstructive pulmonary disease, gout, psoriasis, sinuses and arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications included triamcinolone taken for psoriasis; ibuprofen taken for pain in extremity; nifedipine taken for gastroesophageal reflux disease; famotidine taken one every day for an unspecified indication; salbutamol (ALBUTEROL HFA) taken for an unspecified indication; ascorbic acid (VITAMIN C MP) taken 2 daily for an unspecified indication and unspecified inhaler for her sinuses, start and stop date were not reported. The patient experienced muscle sore, muscle ache, chill, fever, arm pain that she could hardly lift her arm up and joint pain on an unspecified date. It was reported that she had side effects from the shot that she got yesterday for COVID-19. She went for to get her COVID-19 shot yesterday and she had side effects on the where they gave her the shot at her muscle was sore. She was having muscle ache, chill, fever and arm pain. It was reported that she felt like it's gone into her arm, in her armpit she was still freeze. It's kind of say in that progressing little bit. The patient did not receive any treatment in response to the events. The outcome of the events was unknown.   No follow up attempts are needed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: swollen eyes; This is a spontaneous report from a contactable consumer (patient's mother) from a Pfizer sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown) via an unspecified route of administration on 03May2021 as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter wanted to check if swollen eyes are a side effect of the covid-19 vaccine since the patient experienced it when he woke up after getting the vaccine last 03May2021. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever/had little bit of fever; This is a spontaneous report from a contactable consumer (parent) reported for her daughter. A 25-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 intramuscular, administered in left arm on 30Apr2021 12:00 (at the age of 25-year-old) (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 (lot number: unknown, vaccine location: Left arm intramuscularly) on 09Apr2021 for covid-19 immunisation. The patient previously experienced known allergies for egg white since ages. Family medical history includes psoriasis and dermatitis. On 01May2021 at 10:00 the patient experienced fever/had little bit of fever. Where the reporter mentioned that her daughter (patient) also received the vaccine and developed a fever afterwards. It was reported that there was no need of emergency room or physician office was required for the event. Patient received dose 1 vaccine within 4 weeks prior to the vaccination. It was also reported that the adverse events following prior vaccinations were none. Outcome of fever was recovering.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperhidrosis
Clinical narrative: Shortness of breath; Sweats; This is a spontaneous report from a contactable consumer (patient). A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0176) dose 1 via intramuscular route of administration, administered in Deltoid Right on 04May2021 11:30 AM as DOSE 1, SINGLE for covid-19 immunisation (at the age 56 years). Medical history included ongoing hypertension Verbatim: Hypertension (diagnosed around 2011 or 2013). The patient's concomitant medications were not reported. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced shortness of breath and sweats on 04May2021. She reported that she was having a little shortness of breath and sweats. She received the vaccine this morning, 04May2021. The caller clarified she got the first dose of the vaccine today at 11:30AM so her symptoms really did not kick in until 20 minute ago. She was having a little shortness of breath and she was thinking maybe she was just getting a little nervous, but that is not the case. Now, she had got the sweats. The patient not visited emergency room or physician office. The clinical outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever; Body aches; Sore arm; Headache; Cramps; This is a spontaneous report received from a contactable consumer (Patient). A 36-year-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, body aches, sore arm, headache and cramps. The outcome of the events was reported as unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Urticaria
Clinical narrative: huge welts on their lower half and a bit of bruising on both legs; huge welts on their lower half and a bit of bruising on both legs; This is a spontaneous report from a contactable pharmacist. A female patient of unspecified age received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number, Expiration date and NDC number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, about 2 days after getting the first Pfizer COVID-19 vaccine, patient had huge welts on their lower half and a little bit of bruising on both of her legs. Pharmacist wanted to know if patient have the second dose of the Pfizer COVID Vaccine and was there any information related to these side effects. The outcome of both the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.